Sphingosine Kinase 1 (SphK1) overexpression contributes to cetuximab resistance in human colorectal cancer models

نویسندگان

  • Roberta Rosa
  • Roberta Marciano
  • Umberto Malapelle
  • Luigi Formisano
  • Lucia Nappi
  • Claudia D’Amato
  • Valentina D’Amato
  • Vincenzo Damiano
  • Gabriella Marfè
  • Silvana Del Vecchio
  • Antonella Zannetti
  • Adelaide Greco
  • Alfonso De Stefano
  • Chiara Carlomagno
  • Bianca Maria Veneziani
  • Giancarlo Troncone
  • Sabino De Placido
  • Roberto Bianco
چکیده

Dipartimenti di Endocrinologia ed Oncologia Molecolare e Clinica; Scienze Biomorfologiche e Funzionali, Università di Napoli “Federico II”, Naples, Italy; Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Roma "Tor Vergata", Rome, Italy; Institute of Biostructures and Bioimages, National Research Council, Naples, Italy; CEINGE, Biotecnologie Avanzate, Naples, Italy; Dipartimento di Biologia e Patologia Cellulare e Molecolare "L.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.

PURPOSE Although the anti-EGF receptor (EGFR) monoclonal antibody cetuximab is an effective strategy in colorectal cancer therapy, its clinical use is limited by intrinsic or acquired resistance. Alterations in the "sphingolipid rheostat"-the balance between the proapoptotic molecule ceramide and the mitogenic factor sphingosine-1-phosphate (S1P)-due to sphingosine kinase 1 (SphK1) overactivati...

متن کامل

High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer

Background & objective: Breast cancer is the leading cause of cancer related death in females. Sphingosine kinase 1 (SPHK1) and its product sphingosine-1-phosphate (S1P) are the essential key regulator molecules in breast cancer through their ability to promote cell proliferation, angiogenesis, cell proliferation, and lymphagiogenesis. SPHK1 i...

متن کامل

Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.

Systemic chemotherapy was considered of modest efficacy in prostate cancer until the recent introduction of taxanes. We took advantage of the known differential effect of camptothecin and docetaxel on human PC-3 and LNCaP prostate cancer cells to determine their effect on sphingosine kinase-1 (SphK1) activity and subsequent ceramide/sphingosine 1-phosphate (S1P) balance in relation with cell su...

متن کامل

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer

Sphingosine kinase 1 (Sphk1) is a highly conserved lipid kinase that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). Growing studies have demonstrated that Sphk1 is overexpressed in various types of solid cancers and can be induced by growth factors, cytokines, and carcinogens, leading to the increase of S1P production. Subsequently, the increased Sphk1/S1P facilitates cancer ...

متن کامل

Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells.

OBJECTIVE As a better understanding of the molecular basis of carcinogenesis has emerged, oncogene-specific cell-signaling pathways have been successfully targeted to treat human malignances. Despite impressive advances in oncogene-directed therapeutics, genetic instability in cancer cells often manifest acquired resistance. This is particularly noted in the use of tyrosine kinase inhibitors th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012